Clinical Trial Update: Search for Predictive Markers of Efficacy of ESAs in Patients With Non-myeloid Malignancies or Myelodysplastic Syndrome

View source ↗

Summary

A clinical trial assessing predictive markers of erythropoiesis-stimulating agents in patients with non-myeloid malignancies or myelodysplastic syndromes was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Myelodysplastic Syndromes

Snippet

Sponsor: Rennes University Hospital | Conditions: Myelodysplastic Syndromes, Anemia | Status: TERMINATED